Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

Share Price is delayed by 15 minutes
Get Live Data
91.50    0.00 (0.00%)
Bid:
91.40
Ask:
91.50
Spread: 0.10 (0.109%)
Market Cap: £541.75m
BSIF Live PriceLast checked at - London Stock Exchange

Intraday Bluefield Solar Share Chart

Update research from QuotedData

12 Jan 2023 12:32

RNS Number : 5738M
Bluefield Solar Income Fund Limited
12 January 2023
 

 

 

 

Bluefield Solar Income Fund - Update research from QuotedData

12th January 2023

Politicians cloud otherwise bright future

As we describe in this note, there are a lot of moving parts that go into making Bluefield Solar Income Fund (BSIF) run smoothly. However, the net result should be a fund that offers investors attractive, relatively predictable and largely inflation-linked levels of income, plus the prospect of capital growth.

In recent months, the actions of successive UK governments and sharp increases in bond yields have unnerved investors in the sector. This has created some discount volatility for BSIF and its peers.

However, we think that this is a short-term problem. We note that BSIF latest solar plants have secured long-term, predictable, and inflation-linked income through the government's current support mechanism for the industry (which uses contracts for difference - CfDs) - see page 5.

With greater clarity on windfall taxes and the impact of higher discount rates, BSIF's shares are trading closer to net asset value (NAV). The chairman says BSIF's latest acquisition (see page 14) helps underpin the board's confidence in delivering its dividend target of 8.4p per share for the current financial year. We see no reason why BSIF's shares should not return to trading at a premium to NAV.

Full Research:

https://quoteddata.com/research/bluefield-solar-income-fund-politicians-cloud-bright-future-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Bluefield Solar Income Fund Limited and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUUOURORUAAAR
Date   Source Headline
5th Sep 20233:27 pmRNSHolding(s) in Company
24th Aug 202312:47 pmRNSDirector/PDMR Shareholding
23rd Aug 20235:03 pmRNSDirector/PDMR Shareholding
18th Aug 202312:10 pmRNSDirector/PDMR Shareholding
18th Aug 202312:08 pmRNSDirector/PDMR Shareholding
17th Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSUnaudited Net Asset Value as of 30 June 2023
7th Aug 202312:12 pmRNSThird Interim Dividend Announcement - Replacement
7th Aug 20237:00 amRNSThird Interim Dividend Announcement
22nd Jun 20237:00 amRNSRCF Increase and Extension
7th Jun 20237:00 amRNSConclusion of Audit Tender Process
18th May 20235:21 pmRNSChange to Director Roles and Responsibilities
11th May 20237:00 amRNSUnaudited NAV 31 Mar 2023 and 2nd Interim Dividend
2nd May 20237:00 amRNSRe-Financing, Increase & Extension of NatWest Loan
17th Mar 20239:44 amRNSDirector Declaration
8th Mar 20237:00 amRNSChange of Registrar
28th Feb 20237:00 amRNSInterim Results to 31 December 2022
22nd Feb 20233:28 pmRNSDirector Retirement
6th Feb 20237:00 amRNSNotice of Interim Results
23rd Jan 20237:00 amRNSFirst Interim Dividend
12th Jan 202312:32 pmRNSUpdate research from QuotedData
9th Jan 20233:32 pmRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSAcquisition of 46.4MWp Solar Portfolio
8th Dec 20225:45 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:52 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSChange to Director Roles & Responsibilities
29th Nov 20224:32 pmRNSResult of AGM
22nd Nov 20227:00 amRNSSept 22 NAV, Autumn Statement & Development Update
1st Nov 20227:00 amRNSNotice of AGM
20th Oct 20222:20 pmRNSDirector/PDMR Shareholding
17th Oct 20223:01 pmRNSDirector/PDMR Shareholding
14th Oct 20224:27 pmRNSDirector/PDMR Shareholding
14th Oct 20222:03 pmRNSDirector/PDMR Shareholding
13th Oct 20225:02 pmRNSDirector/PDMR Shareholding
7th Oct 20221:37 pmRNSDirector Appointment
6th Oct 20221:57 pmRNSDirector/PDMR Shareholding
4th Oct 20221:59 pmRNSDirector/PDMR Shareholding
3rd Oct 20223:56 pmRNSDirector/PDMR Shareholding
30th Sep 20225:11 pmRNSDirector/PDMR Shareholding
30th Sep 20227:01 amRNSFourth Interim Dividend Announcement
30th Sep 20227:00 amRNSAnnual Report for the Year Ended 30 June 2022
29th Sep 20227:00 amRNSChange to Director Roles and Responsibilities
23rd Sep 20227:00 amRNSPromotion to the FTSE 250
23rd Sep 20227:00 amRNSPromotion to the FTSE 250
22nd Sep 202210:49 amRNSDirector Notification
15th Sep 202211:31 amRNSDirector Declaration
22nd Aug 20227:00 amRNSUNAUDITED NET ASSET VALUE AS OF 30 JUNE 2022
17th Aug 202212:10 pmRNSThird Interim Dividend
15th Aug 20227:00 amRNS62.4MW Solar Contracts for Difference Secured
2nd Aug 20227:00 amRNSThird Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.